STAGE IB BREAST CANCER
Clinical trials for STAGE IB BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IB BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IB BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a week of radiation be enough for breast cancer?
Disease control OngoingThis study compares a 1-week radiation schedule to the standard 3-week schedule for people with early-stage breast cancer who have had breast-conserving surgery. The goal is to see if the shorter treatment works just as well at controlling cancer and has fewer side effects. About…
Matched conditions: STAGE IB BREAST CANCER
Phase: NA • Sponsor: Coordinación de Investigación en Salud, Mexico • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Could adding carboplatin beat triple-negative breast cancer?
Disease control OngoingThis study tested whether adding a drug called carboplatin to standard chemotherapy helps people with triple-negative breast cancer live longer without the cancer coming back. About 782 people with high-risk or node-positive breast cancer took part. The goal was to see if the str…
Matched conditions: STAGE IB BREAST CANCER
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
One-Time radiation boost during breast surgery shows promise in Early-Stage cancer trial
Disease control OngoingThis study tests whether giving a single dose of radiation directly to the tumor site during breast-conserving surgery (lumpectomy) and before reconstruction is safe and effective for women with early-stage breast cancer. About 108 participants with stage I-II breast cancer will …
Matched conditions: STAGE IB BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC